Research/art/teacher profile of a person
Name and surname:
prof. MUDr. Dalibor Ondruš, DrSc.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Ondruš
I.2 - Name
Dalibor
I.3 - Degrees
Prof. MUDr. DrSc.
I.4 - Year of birth
1953
I.5 - Name of the workplace
Comenius University, Faculty of Medicine, 1st Department of Oncology
I.6 - Address of the workplace
St. Elisabeth Cancer Institute, Heydukova 10, 812 50 Bratislava
I.7 - Position
Head of the department
I.8 - E-mail address
dalibor.ondrus@ousa.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
www.portalvs.sk/regzam/detail/3319
I.10 - Name of the study field in which a person works at the university
oncology, clinical oncology, urology
I.11 - ORCID iD
https://orcid.org/0000-0001-9666-0035

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
1977
II.c - Study field and programme
General Medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
1988
II.c - Study field and programme
Surgery
II.4 - Associate professor
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
1992
II.c - Study field and programme
urology - clinical oncology
II.5 - Professor
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
1999
II.c - Study field and programme
oncology
II.6 - Doctor of Science (DrSc.)
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2001
II.c - Study field and programme
Surgery

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
assistant, assistant professor, associate profesor, professor Comenius University in Bratislava, Faculty of Medicine 1977 - until now

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Board certification from urology I Slovak Medical University, Bratislava 1981
Board certification from urology II Slovak Medical University, Bratisava 1985
Board certification from clinical oncology Slovak Medical University, Bratislava 1988

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Oncological Propedeutics General Medicine I. + II. General Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
Oncology III. General Medicine
Urology III. General Medicine
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.3.a - Name of the field of habilitation procedure and inaugural procedure V.3.b - Study field to which it is assigned
Oncology General Medicine
Urology General Medicine
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.c - Dissertation (third degree)
2
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
2
V.4.c - Dissertation (third degree)
8
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
653
VI.1.b - Over the last six years
114
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
160
VI.1.b - Over the last six years
31
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
2337
VI.1.b - Over the last six years
748
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
1575
VI.1.b - Over the last six years
600
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W. (... Ondruš D.) et al.: European concensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part I. European Urology, 2008; 53(3): 478-496. (WoS, SCOPUS): IF 6,512, Q1 https://app.crepc.sk/?fn=detailBiblioForm&sid=4CC35374634BFBBA5F127678E8

2

Ondruš, D., Ondrušová, M, Friedová, L.: Second malignancies in long- term testicular cancer survivors. International Urology and Nephrology, 2014; 46(4): 749-756.IF 1,519, Q3

https://app.crepc.sk/?fn=detailBiblioForm&sid=AD470EB76284829283C3D7F385

3

Ondrušová, M., Waczulíková, I., Lehotská, V., Zelený, T., Ondruš, D.: Management of clinical stage I nonseminomatous germ cell testicular tumors: a 25-year single-center experience. Clinical Genitourinary Cancer, 2017; 15(6): e1015-e101 IF 2,539, Q1

https://app.crepc.sk/?fn=detailBiblioForm&sid=6C8E7CD34090E17FA1BE8839E6

4

Honecker, F., Aparicio, J., Berney, D., Beyer, J., Bokemeyer, C. ... (Ondruš, D.) et al.: ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Annals of Oncology, 2018; 29(8): 1658-1686: (WoS, SCOPUS): IF=14,196, Q1. https://app.crepc.sk/?fn=detailBiblioForm&sid=EC1A4D157169299A7BB46C5E

5
Ondrušová, M., Špániková, B., Krajcovics, K., Ondruš, D.: Testosterone deficiency and bone metabolism damage in testicular cancer survivors. American journal of men's health, 2018; 12(3): 628-633 (WoS, SCOPUS): IF 1,409, Q2. https://app.crepc.sk/?fn=detailBiblioForm&sid=434808BB42BA547A1C51ED5F

VI.3 - The most significant research/artistic/other outputs over the last six years
1
Fillo, J., Levčíková, M., Luha, J., Ondruš, D. The effect of long term testosterone replacement therapy on bone mineral density. Bratislava medical journal, 2019; 120(4): 291-294. IF 1,200, Q3

https://app.crepc.sk/?fn=detailBiblioForm&sid=180EDEFD59FD42974E2352B590

2

Fedorková, L., Ondruš, D.: Zhubné nádory krčka maternice v gravidite = Cervical cancer in pregnancy. Klinická onkologie, 2020; 33(4): 268-273. (SCOPUS): Q4.

https://app.crepc.sk/?fn=detailBiblioForm&sid=4F0833F4105B54F982B6E02402

3

Mriňáková, B., Kajo, K., Lehotská, V., Ondrušová, M., Balogová, S., Piňáková, Z., Novotná, V., Ušáková, V., Fedorková, L., Waczulíková, I., Kaušitz, J., Ondruš, D.: Stage I testicular seminoma risk-adapted therapeutic management. Neoplasma, 2021; 68(3): 613-620 (WoS, SCOPUS): IF 3,309, Q2

https://app.crepc.sk/?fn=detailBiblioForm&sid=9A2012D09B493E7D90915EDF0A

4

Mriňáková, B., Trebatický, B., Kajo, K., Ondrušová, M., Lehotská, V., Waczulíková, I., Ondruš, D.: Bilateral testicular germ cell tumors - 50 years experience. Bratislava medical journal, 2021; 122(7): 449-53 IF 1,5, Q2

 https://app.crepc.sk/?fn=detailBiblioForm&sid=26E19CB57E1984FE7CAAEE77E2

VI.4 - Najvýznamnejšie ohlasy

5

Leško P, Obertová J, Kajo K, Rejleková K, Országhová Z, Lehotská V, Ondrušová M, Chovanec M, Ondruš D, Mego M.: Testicular seminoma in prostate: Case report and review of literature. Clinical Genitourinary Cancer. 2024; 22(2): 210-216, IF 2,30, Q1

https://app.crepc.sk/?fn=detailBiblioForm&sid=E52557BEC79C1752D0B3717AD782

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Ondrus, D., Maťoška, J., Belan, V. Kaušitz, J., Goncalves, F. et al.: Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment. Eur. Urol., 1998; 33(6): 562-566. CITATION: Schmoll, H.-J., Souchon, R., Krege, S., Albers, P., Beyer, J. et al.: European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG): Annals of Oncology. 2004; 15(9): 1377-1399.

 

2

Ondrusova, M., Ondrus, D., Dusek, L., Spanikova, B.: Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer. Neoplasma, 2009; 56(5): 473-479. CITATION: Fung, C., Dinh, P.C., Fossa, S.D., Travis, L.B.: Testicular cancer survivorship. J. Natl. Compr. Canc. Netw, 2019; 17(12): 1557-1568.

3

Ondrusova, M., Spanikova, B., Sevcikova, K., Ondrus, D.: Testosterone deficiency and bone metabolism damage in testicular cancer survivors. American Journal of Men's Health, 2018; 12(3): 628-633. CITATION: Chovanec, M., Abu Zaid, M., Hanna, N., El Kouri, N., Einhorn, L.H. et al.: Long-term toxicity of cisplatin in germ-cell tumor survivors. Annals of Oncology. 2017; 28(11): 2670-2679.

4

Honecker, F., Aparicio, J., Berney, D., Beyer, J., Bokemeyer, C. ... Ondruš, D. et al.: ESMO Consensus Conference on testicular germ cell cancer:diagnosis, treatment and follow-up. Annals of Oncology. 2018; 29 (8): 1658-1686. CITATION: Jiang, S., Sun, L., Jiang, H.: Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: a US population-based analysis. Current Problems in Cancer, 2021; 45 (2): art. no. 100641.

5

Mriňáková, B., Kajo, K., Lehotská, V., Ondrušová, M., Balogová, S., Piňáková, Z., Novotná, V., Ušáková, V., Fedorková, L., Waczulíková, I., Kaušitz, J., Ondruš, D.: Stage I testicular seminoma risk-adapted therapeutic management. Neoplasma, 2021; 68 (3): 613-620 (WoS, SCOPUS): IF 3,309, Q2. CITATION: Heidenreich, A., Seelemeyer, F., Altay, B. et al.:Testis-sparing surgery in adult patients with cerm cell tumors: Systematic search of the literature and focused review. European urology focus.2023; 9(2): 244-247. WOS CC.

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
Scientific board member Comenius University in Bratislava, Faculty of Medicine 2011 - Until now
Member of the top scientific team - TRANSONK Comenius University in Bratislava, Faculty of Medicine 2017 - Until now
Member of the Academic Senate Univerzita Komenského v Bratislave, Lekárska fakulta 2000 - Until now
Guarantor of the habilitation procedure and the procedure for appointing professors in the field of study oncology Comenius University in Bratislava, Faculty of Medicine 2005 - Until now
Guarantor of doctoral studies in the field of oncology Univerzita Komenského v Bratislave, Lekárska fakulta 2005 - doteraz

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Awards: silver medal SMA, gold medal SMA, bronze medal LFUK in Bratislava, silver medal LFUK in Bratislava, award of the Slovak Urological Society (repeatedly), Award of the Slovak Oncology Society (repeatedly), Literary Fund's premium for scientific literature (repeatedly), Jessenius Prize SMA for publishing, SMA church (repeatedly), honorary membership: Slovak Urological Society, Czech Urological Society, Czech Oncology Society, EORTC Membership, Membership of European Germ Cell Cancer Consensus Group, Editorial board membership - journals: Klinická urológia, Klinická onkológia, Onkológia (Bratislava), Revue Medicine in Practice, Medical Horizon, Iranian Red Crescent Medical Journal.

Date of last update
2025-01-30